Irisin, an adipomyokine identified in 2012, has been investigated in association with common pregnancy complications, including gestational diabetes mellitus, preeclampsia, and intrauterine growth restriction. The objective of this study is to examine the potential role of irisin in preterm birth (PTB) by comparing its level between mothers with term and preterm labor. Maternal peripheral blood and cord blood samples were collected from 30 mothers who delivered prematurely and from 35 mothers who delivered at term. Irisin concentrations were measured in all samples using ELISA, and four common single nucleotide polymorphisms in the irisin gene were determined (rs16835198, rs726344, rs3480, and rs1746661). Univariable and multivariable regression modeling was applied to evaluate maternal and cord blood irisin concentrations in relation to preterm/term labor. Irisin concentration in umbilical cord blood was found to be associated with PTB in the univariable model (p = 0.046). On the other hand, no differences in maternal blood irisin levels between mothers with preterm and term deliveries were established. To the best of our knowledge, this is the first study determining irisin levels in term and preterm deliveries in maternal peripheral blood and umbilical cord blood. Our study shows a possible association between cord blood irisin concentration and PTB occurrence.

Department of Biochemistry Faculty of Medicine Masaryk University Brno Czech Republic

Department of Obstetrics and Gynaecology University Hospital Brno Brno Czech Republic

Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czech Republic

Research Centre for Toxic Compounds in the Environment Faculty of Science Masaryk University Brno Czech Republic

See more in PubMed

Blencowe H., Cousens S., Oestergaard M. Z., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. The Lancet. 2012;379(9832):2162–2172. doi: 10.1016/S0140-6736(12)60820-4. PubMed DOI

WHO. Preterm birth. November 2017, http://www.who.int/mediacentre/factsheets/fs363/en/

Goldenberg R. L., Culhane J. F., Iams J. D., Romero R. Epidemiology and causes of preterm birth. The Lancet. 2008;371(9606):75–84. doi: 10.1016/S0140-6736(08)60074-4. PubMed DOI PMC

Medina T. M., Hill D. A. Preterm premature rupture of membranes: diagnosis and management. American Family Physician. 2006;73(4):659–664. PubMed

D'Ippolito S., Tersigni C., Scambia G., Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. BioFactors. 2012;38(1):14–23. doi: 10.1002/biof.201. PubMed DOI

Mazaki-Tovi S., Vaisbuch E., Romero R. Adipokines and pathophysiology of pregnancy complications – the role of leptin and adiponectin. Fetal and Maternal Medicine Review. 2013;24(4):232–259. doi: 10.1017/S0965539514000011. DOI

AlSaif S., Mumtaz S., Wray S. A short review of adipokines, smooth muscle and uterine contractility. Life Sciences. 2015;125:2–8. doi: 10.1016/j.lfs.2015.02.001. PubMed DOI

Hajagos-Tóth J., Ducza E., Samavati R., Vari S. G., Gaspar R. Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility. Croatian Medical Journal. 2017;58(2):96–104. doi: 10.3325/cmj.2017.58.96. PubMed DOI PMC

Yeung E. H., McLain A. C., Anderson N., et al. Newborn adipokines and birth outcomes. Paediatric and Perinatal Epidemiology. 2015;29(4):317–325. doi: 10.1111/ppe.12203. PubMed DOI PMC

Briana D. D., Malamitsi-Puchner A. The role of adipocytokines in fetal growth. Annals of the New York Academy of Sciences. 2010;1205(1):82–87. doi: 10.1111/j.1749-6632.2010.05650.x. PubMed DOI

Boström P., Wu J., Jedrychowski M. P., et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–468. doi: 10.1038/nature10777. PubMed DOI PMC

Roca-Rivada A., Castelao C., Senin L. L., et al. FNDC5/Irisin is not only a myokine but also an adipokine. PLoS One. 2013;8(4, article e60563) doi: 10.1371/journal.pone.0060563. PubMed DOI PMC

Castillo-Quan J. I. From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity. Disease Models & Mechanisms. 2012;5(3):293–295. doi: 10.1242/dmm.009894. PubMed DOI PMC

Aydin S., Kuloglu T., Aydin S. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus. Peptides. 2013;47:66–70. doi: 10.1016/j.peptides.2013.07.001. PubMed DOI

Ebert T., Stepan H., Schrey S., et al. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine. 2014;65(2):153–158. doi: 10.1016/j.cyto.2013.11.009. PubMed DOI

Erol O., Erkal N., Ellidağ H. Y., et al. Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study. The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(22):3590–3595. doi: 10.3109/14767058.2016.1142967. PubMed DOI

Kralisch S., Hoffmann A., Kratzsch J., et al. The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus. Diabetes & Metabolism. 2018;44(2):150–154. doi: 10.1016/j.diabet.2017.06.001. PubMed DOI

Kuzmicki M., Telejko B., Lipinska D., et al. Serum irisin concentration in women with gestational diabetes. Gynecological Endocrinology. 2014;30(9):636–639. doi: 10.3109/09513590.2014.920006. PubMed DOI

Piya M. K., Harte A. L., Sivakumar K., et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. American Journal of Physiology Endocrinology and Metabolism. 2014;306(5):E512–E518. doi: 10.1152/ajpendo.00308.2013. PubMed DOI

Usluoğullari B., Usluogullari C. A., Balkan F., Orkmez M. Role of serum levels of irisin and oxidative stress markers in pregnant women with and without gestational diabetes. Gynecological Endocrinology. 2017;33(5):405–407. doi: 10.1080/09513590.2017.1284789. PubMed DOI

Wawrusiewicz-Kurylonek N., Telejko B., Kuzmicki M., et al. Increased maternal and cord blood betatrophin in gestational diabetes. PLoS One. 2015;10(6, article e0131171) doi: 10.1371/journal.pone.0131171. PubMed DOI PMC

Yuksel M. A., Oncul M., Tuten A., et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Research and Clinical Practice. 2014;104(1):171–175. doi: 10.1016/j.diabres.2013.12.025. PubMed DOI

Zhao L., Li J., Li Z.-L., Yang J., Li M.-L., Wang G.-L. Circulating irisin is lower in gestational diabetes mellitus. Endocrine Journal. 2015;62(10):921–926. doi: 10.1507/endocrj.EJ15-0230. PubMed DOI

Zhang W., Chang L., Zhang C., et al. Central and peripheral irisin differentially regulate blood pressure. Cardiovascular Drugs and Therapy. 2015;29(2):121–127. doi: 10.1007/s10557-015-6580-y. PubMed DOI PMC

Garcés M. F., Peralta J. J., Ruiz-Linares C. E., et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia. The Journal of Clinical Endocrinology & Metabolism. 2014;99(6):2113–2119. doi: 10.1210/jc.2013-4127. PubMed DOI

Zhang L.-J., Xie Q., Tang C.-S., Zhang A.-H. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia. Clinical and Experimental Hypertension. 2017;39(5):460–467. doi: 10.1080/10641963.2016.1273945. PubMed DOI

Aydin S. Three new players in energy regulation: preptin, adropin and irisin. Peptides. 2014;56:94–110. doi: 10.1016/j.peptides.2014.03.021. PubMed DOI

Çağlar M., Göksu M., Isenlik B. S., et al. Irisin in idiopathic foetal growth restriction. Journal of Endocrinological Investigation. 2014;37(7):619–624. doi: 10.1007/s40618-014-0078-5. PubMed DOI

Baka S., Malamitsi-Puchner A., Boutsikou T., et al. Cord blood irisin at the extremes of fetal growth. Metabolism – Clinical and Experimental. 2015;64(11):1515–1520. doi: 10.1016/j.metabol.2015.07.020. PubMed DOI

Briana D. D., Boutsikou M., Athanasopoulos N., Marmarinos A., Gourgiotis D., Malamitsi-Puchner A. Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth. The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(21):1–20. doi: 10.3109/14767058.2015.1137283. PubMed DOI

Untergasser A., Cutcutache I., Koressaar T., et al. Primer3—new capabilities and interfaces. Nucleic Acids Research. 2012;40(15, article e115) doi: 10.1093/nar/gks596. PubMed DOI PMC

Royston P., White I. R. Multiple imputation by chained equations (MICE): implementation in Stata|. Journal of Statistical Software. 2011;45(4) doi: 10.18637/jss.v045.i04. DOI

Tanisawa K., Taniguchi H., Sun X., et al. Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels. Metabolism – Clinical and Experimental. 2014;63(4):574–583. doi: 10.1016/j.metabol.2014.01.005. PubMed DOI

Ebert T., Kralisch S., Wurst U., et al. Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations. International Journal of Obesity. 2016;40(2):260–265. doi: 10.1038/ijo.2015.157. PubMed DOI

Salem H., Yatchenko Y., Anosov M., et al. Maternal and neonatal irisin precursor gene FNDC5 polymorphism is associated with preterm birth. Gene. 2018;649:58–62. doi: 10.1016/j.gene.2018.01.097. PubMed DOI

Stengel A., Hofmann T., Goebel-Stengel M., Elbelt U., Kobelt P., Klapp B. F. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – correlation with body mass index. Peptides. 2013;39:125–130. doi: 10.1016/j.peptides.2012.11.014. PubMed DOI

Moreno-Navarrete J. M., Ortega F., Serrano M., et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. The Journal of Clinical Endocrinology & Metabolism. 2013;98(4):E769–E778. doi: 10.1210/jc.2012-2749. PubMed DOI

Huh J. Y., Panagiotou G., Mougios V., et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism – Clinical and Experimental. 2012;61(12):1725–1738. doi: 10.1016/j.metabol.2012.09.002. PubMed DOI PMC

Pardo M., Crujeiras A. B., Amil M., et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. International Journal of Endocrinology. 2014;2014:9. doi: 10.1155/2014/857270.857270 PubMed DOI PMC

Crujeiras A. B., Zulet M. A., Lopez-Legarrea P., et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism – Clinical and Experimental. 2014;63(4):520–531. doi: 10.1016/j.metabol.2013.12.007. PubMed DOI

Lewis C. E., Smith D. E., Caveny J. L., Perkins L. L., Burke G. L., Bild D. E. Associations of body mass and body fat distribution with parity among African-American and Caucasian women: the CARDIA study. Obesity Research. 1994;2(6):517–525. doi: 10.1002/j.1550-8528.1994.tb00100.x. PubMed DOI

Lassek W. D., Gaulin S. J. C. Changes in body fat distribution in relation to parity in American women: a covert form of maternal depletion. American Journal of Physical Anthropology. 2006;131(2):295–302. doi: 10.1002/ajpa.20394. PubMed DOI

Szumilewicz A., Worska A., Piernicka M., et al. The exercise-induced irisin is associated with improved levels of glucose homeostasis markers in pregnant women participating in 8-week prenatal group fitness program: a pilot study. BioMed Research International. 2017;2017:10. doi: 10.1155/2017/9414525.9414525 PubMed DOI PMC

Foda A. A., Foda E. A. Effects of delivery on maternal & neonatal irisin levels in normal and preeclamptic pregnant women. Pregnancy Hypertension. 2017;10:226–229. doi: 10.1016/j.preghy.2017.10.003. PubMed DOI

Hernandez-Trejo M., Garcia-Rivas G., Torres-Quintanilla A., Laresgoiti-Servitje E. Relationship between irisin concentration and serum cytokines in mother and newborn. PLoS One. 2016;11(11, article e0165229) doi: 10.1371/journal.pone.0165229. PubMed DOI PMC

Sonagra A. D., Biradar S. M., Dattatreya K., Jayaprakash Murthy D. S. Normal pregnancy- a state of insulin resistance. Journal of Clinical and Diagnostic Research. 2014;8(11):CC01–CC03. doi: 10.7860/JCDR/2014/10068.5081. PubMed DOI PMC

Albrecht E., Norheim F., Thiede B., et al. Irisin – a myth rather than an exercise-inducible myokine. Scientific Reports. 2015;5(1):p. 8889. doi: 10.1038/srep08889. PubMed DOI PMC

Polyzos S. A., Mantzoros C. S. An update on the validity of irisin assays and the link between irisin and hepatic metabolism. Metabolism - Clinical and Experimental. 2015;64(9):937–942. doi: 10.1016/j.metabol.2015.06.005. PubMed DOI

Polyzos S. A., Mathew H., Mantzoros C. S. Irisin: a true, circulating hormone. Metabolism - Clinical and Experimental. 2015;64(12):1611–1618. doi: 10.1016/j.metabol.2015.09.001. PubMed DOI

Jedrychowski M. P., Wrann C. D., Paulo J. A., et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metabolism. 2015;22(4):734–740. doi: 10.1016/j.cmet.2015.08.001. PubMed DOI PMC

Boström P. A., Fernández-Real J. M., Mantzoros C. Irisin in humans: recent advances and questions for future research. Metabolism - Clinical and Experimental. 2014;63(2):178–180. doi: 10.1016/j.metabol.2013.11.009. PubMed DOI

Huh J. Y., Mantzoros C. S. Irisin physiology, oxidative stress, and thyroid dysfunction: what next? Metabolism - Clinical and Experimental. 2015;64(7):765–767. doi: 10.1016/j.metabol.2015.02.009. PubMed DOI

Zhang Y., Li R., Meng Y., et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63(2):514–525. doi: 10.2337/db13-1106. PubMed DOI

Cavalier É., Mismetti V., Souberbielle J.-C. Evaluation of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose. Annales d'Endocrinologie. 2014;75(3):162–164. doi: 10.1016/j.ando.2014.05.005. PubMed DOI

The Role of the Adipokines in the Most Common Gestational Complications